RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $469,764 | -33.3% | 28,265 | -25.0% | 0.00% | – |
| Q2 2023 | $704,411 | -1.4% | 37,669 | -3.3% | 0.00% | – |
| Q1 2023 | $714,677 | +3661.5% | 38,947 | +4964.6% | 0.00% | – |
| Q3 2022 | $19,000 | +90.0% | 769 | +36.1% | 0.00% | – |
| Q2 2022 | $10,000 | -92.8% | 565 | -91.1% | 0.00% | – |
| Q1 2022 | $139,000 | -71.6% | 6,321 | -52.6% | 0.00% | – |
| Q4 2021 | $489,000 | +5333.3% | 13,325 | +4608.5% | 0.00% | – |
| Q3 2021 | $9,000 | -35.7% | 283 | -37.1% | 0.00% | – |
| Q2 2021 | $14,000 | -75.9% | 450 | -83.0% | 0.00% | – |
| Q1 2021 | $58,000 | -90.3% | 2,652 | -91.2% | 0.00% | – |
| Q4 2020 | $597,000 | -62.9% | 30,227 | -39.5% | 0.00% | – |
| Q3 2020 | $1,609,000 | +30.8% | 49,975 | +17.9% | 0.00% | – |
| Q2 2020 | $1,230,000 | +333.1% | 42,395 | +217.3% | 0.00% | – |
| Q1 2020 | $284,000 | +6.8% | 13,363 | +38.5% | 0.00% | – |
| Q4 2019 | $266,000 | – | 9,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |